Patient Specific Optimized Therapy (PSOT) in Atrial Flutter Population Miami Cardiac & Vascular Institute (MCVI) Post Marketing Surveillance (PMS) Study
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 566
- 试验地点
- 1
- 主要终点
- Arrhythmia recurrence The number of Arrhythmia recurrence
研究概览
简要总结
Data collection from atrial flutter patients before, during and after undergoing catheter-based electrophysiological (EP) intervention in order to develop a patient specific optimized therapy (PSOT) to improve specific patient's arrhythmia treatment for Atrial Flutter.
详细描述
Prospective, single-center, non-randomized, open label, single arm study. Consented subjects who are scheduled to undergo ablation due to atrial flutter will be enrolled in the study. Data will be collected from all subjects during the ablation procedure and post procedure for a period of 3 months.
KODEX - EPD™ system will be used in all procedures during treatment of cardiac arrhythmias.
Anonymized data will be stored in an EPD database and will be used to train and test predictors for personalized optimized therapy.
Data will be collected on paper and/or electronic forms and saved in the EPD Database.
Advanced data analysis will be used to map patient specific demographics, history, current ailment, intervention to patient outcome. The technology to be utilized will help develop a method to identify the personalized treatment for a given patient (defined by: patient's demographic, history, current ailment and intervention information to achieve optimal outcome).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject is at least 18 years of age.
- •Subject signed a written Informed Consent form to participate in the study, prior to any study related procedures.
- •Subject is willing to comply with the protocol requirements and return to the treatment center for all required clinical evaluations.
- •A female subject is eligible if not of child bearing potential or has a negative pregnancy test within the previous 7 days.
- •Subject is deemed amenable to therapeutic ablation for atrial flutter.
排除标准
- •Any planned surgical or endovascular intervention within 30 days before or after the index procedure.
- •Subject is enrolled in another drug or device study protocol that has not reached its primary endpoint.
- •Patient had experienced previous stroke (TIA or CVA).
- •Thrombi detected in the heart.
- •Known marked valvar insufficiency.
- •Life expectancy less than 12 months.
- •Known severe renal insufficiency.
结局指标
主要结局
Arrhythmia recurrence The number of Arrhythmia recurrence
时间窗: 3 months
The number of arrhythmia recurrence
次要结局
未报告次要终点